Identification and validation of LY6H and GRM3 as candidate biomarkers for Glioma-related epilepsy

Sample acquisition

Following treatment protocols, glioma resection and epileptic focus excision surgeries were performed, with samples obtained intraoperatively for GRE (experimental group) and glioma none epilepsy (control group). All samples…

Continue Reading